Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ROS1
Pharma
GSK prepares frontline FDA bid for lung cancer drug Jideytro
In what GSK’s oncology R&D chief Hesham Abdullah called “quite dramatic,” Jideytro led to a 15% complete response rate in TKI-naïve NSCLC patients.
Angus Liu
Sep 13, 2026 7:00pm
Nuvalent deal delivers GSK’s first-ever lung cancer approval
Jul 22, 2026 3:15pm
With lung cancer FDA nod, it's David versus Goliath
Jun 11, 2025 4:17pm
Ready to rumble: Roche scores Rozlytrek OK to challenge Bayer
Aug 15, 2019 5:11pm
